Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Total Voting Rights

August 2, 2021
RNS Number : 2696H Renalytix PLC 02 August 2021   Renalytix plc   (" Renalytix " or the " Company ")     Total voting rights   New York , 2 August 2021 - Renalytix (LSE: RENX) announces that t he Company's total issued share capital consists of 72,229,786   shares of 0.25 pence each, with each

Director/PDMR Dealing

July 30, 2021
RNS Number : 1332H Renalytix PLC 30 July 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 30 July 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O . James Sterling , the Company's Chief Financial Officer, of 12,000

Appointment of Ann Berman to Board of Directors

July 28, 2021
RNS Number : 6767G Renalytix PLC 28 July 2021     Renalytix Appoints Ann Berman to its Board of Directors   Berman serves on the board of Lowes Corporation , is a member of the board of trustees of Beth Israel Deaconess , and is a former chief financial officer of Harvard University     NEW YORK

Director/PDMR Shareholding

July 23, 2021
RNS Number : 3061G Renalytix PLC 23 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 23 July 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000

VP of Global Quality and Regulatory Appointment

July 22, 2021
RNS Number : 0685G Renalytix PLC 22 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Renalytix Appoints Joseph Hutson Vice President of Global Quality and Regulatory   Hutson To Build-on Renalytix Quality and Regulatory Strategy for KidneyIntelX Global Commercialization   NEW YORK

Exercise of Options and TVR

July 19, 2021
RNS Number : 7167F Renalytix PLC 19 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Exercise of Options and TVR   NEW YORK , 19 July, 2021 - Renalytix plc (AIM: RENX) announces that it has issued and allotted 5,000 ordinary shares of 0.25 pence each in the share capital of the

Exercise of options, PDMR transaction and TVR

July 7, 2021
RNS Number : 3722E Renalytix PLC 07 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Exercise of options, PDMR transaction and TVR   NEW YORK , 7 July, 2021 - The Board of   Renalytix plc (LSE: RENX) announces that it has issued and allotted 27,500 ordinary shares of 0.25 pence

Directorate Change

July 1, 2021
RNS Number : 9118D Renalytix PLC 01 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Death of Director     NEW YORK , 1 July, 2021 - The Board of   Renalytix plc (LSE: RENX) (NASDAQ: RNLX) is saddened to announce the death of Dr. Barbara Murphy , Non-Executive Director and

Total Voting Rights

July 1, 2021
RNS Number : 7147D Renalytix PLC 01 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Total voting rights   The Company's total issued share capital consists of 72,197,286 shares of 0.25 pence each, with each share carrying the right to one vote.

Director/PDMR Shareholding

June 28, 2021
RNS Number : 3397D Renalytix PLC 28 June 2021   Renalytix plc    ("Renalytix" or the "Company")   Director/PDMR Dealing   The Company had been informed today that Christopher Mills , a non-executive director and interim Chairman, completed the sale of 6,100 ordinary shares of 0.25 pence each
Displaying 61 - 70 of 209